OraSure Technologies | OSUR - Selling And Administration Expenses


OraSure Technologies reported $13.21M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Agilent USD 475M 10M Jun/2026
AngioDynamics USD 36.57M 3.79M Sep/2025
Becton, Dickinson and Co. USD 1.26B 48M Jun/2026
Bio Techne USD 67.42M 41.91M Jun/2026
Bio-Rad Laboratories USD 212M 400K Jun/2026
Bruker USD 226.5M 12.4M Sep/2026
Cerus USD 19.33M 1.55M Dec/2024
Charles River Laboratories USD 140.59M 88.31M Sep/2026
Danaher USD 2.16B 87M Sep/2026
Dentsply International USD 364M 13M Jun/2026
Dexcom USD 358.7M 9M Jun/2026
Illumina USD 281M 8M Sep/2026
Integra LifeSciences USD 161.02M 5.2M Sep/2026
Intuitive Surgical USD 1.08B 465.5M Sep/2026
IQVIA Holdings USD 569M 5M Sep/2026
Mesa Laboratories USD 27.31M 380K Sep/2024
Mettler Toledo International USD 263.33M 5.01M Jun/2026
Myriad Genetics USD 122.3M 6.7M Dec/2025
OraSure Technologies USD 13.21M 3.29M Dec/2025
Quidel USD 182.7M 7M Sep/2026
Repligen USD 83.59M 6.97M Sep/2026
Revvity USD 275.33M 3.25M Sep/2026
STAAR Surgical USD 43.22M 1.92M Sep/2026
Thermo Fisher Scientific USD 1.86B 46M Sep/2026
Trinity Biotech USD 4.71M 1.08M Mar/2026
Waters USD 398M 7M Sep/2026